ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Warszawa, Mazowieckie

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Warszawa, Mazowieckie, POL:

Adjuvant Palbociclib in Elderly Patients With Breast Cancer (Appalaches)

adjuvant systemic treatment instead of adjuvant chemotherapy followed by endocrine therapy in older patients with stage II-III ER+/HER2- early breast...

Active, not recruiting
Breast Cancer Stage II
Breast Cancer Stage III
Drug: Palbociclib
Drug: Docetaxel / cyclophosphamide

Phase 2

European Organisation for Research and Treatment of Cancer (EORTC)

Warsaw, Poland and 72 other locations

look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...

Active, not recruiting
HER2-positive Early Breast Cancer
Breast Cancer
Drug: Pertuzumab
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Warszawa, Poland and 147 other locations

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....

Enrolling
Advanced Breast Cancer
Drug: ARV-471
Drug: Fulvestrant

Phase 3

Pfizer
Pfizer

Warszawa, Mazowieckie, Poland and 324 other locations

in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple negative breast...

Active, not recruiting
Triple Negative Breast Neoplasms
Drug: Capivasertib
Drug: Trastuzumab deruxtecan

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Warszawa, Poland and 31 other locations

with inoperable or metastatic HR-positive, HER2- negative breast cancer who have been treated with one or two prior lines of...

Active, not recruiting
Breast Cancer
Drug: Eribulin
Drug: Vinorelbine

Phase 3

AstraZeneca
AstraZeneca

Warszawa, Poland and 166 other locations

(BMs), with previously-treated advanced/metastatic HER2-positive breast cancer whose disease has progressed on prior anti-HER2-base...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab Deruxtecan

Phase 3

AstraZeneca
AstraZeneca

Warszawa, Poland and 80 other locations

of fulvestrant or an aromatase inhibitor in women and men with breast cancer whose disease has advanced on one endocrine therapy in...

Enrolling
Breast Cancer
ER Positive Breast Cancer
Drug: Letrozole
Drug: Exemestane

Phase 3

Olema Pharmaceuticals

Otwock, Mazowieckie, Poland and 170 other locations

patients with locally advanced (inoperable) or metastatic HR+/HER2- breast cancer following recurrence or progression on or after A...

Active, not recruiting
Locally Advanced (Inoperable) or Metastatic Breast Cancer
Drug: Capivasertib
Drug: Fulvestrant

Phase 3

AstraZeneca
AstraZeneca

Warszawa, Poland and 214 other locations

growth factor receptor (HER)2-low, hormone receptor (HR) positive breast cancer patients whose disease has progressed on endocrine ...

Active, not recruiting
Advanced or Metastatic Breast Cancer
Drug: Trastuzumab deruxtecan
Drug: Capecitabine

Phase 3

AstraZeneca
AstraZeneca

Warszawa, Poland and 293 other locations

and Fulvestrant in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced, Unresectable or Metastatic Breast...

Enrolling
Locally Advanced (Inoperable) or Metastatic Breast Cancer
Drug: Palbociclib
Drug: Capivasertib

Phase 3

AstraZeneca
AstraZeneca

Warszawa, Poland and 242 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems